Pharma Commons

Aggregating pharma news and events. Created by @wjjessen

[Pharma Commons @PharmaCommons]

Mylan signs U.S. license deal on Humira with AbbVie https://t.co/rpvQDxN7cb

[Pharma Commons @PharmaCommons]

With FDA nod, Pfizer and Astellas’ Xtandi gets its shot at blockbuster sales boost https://t.co/n8ulyAIVsX

[Pharma Commons @PharmaCommons]

Pfizer, Astellas' Xtandi OK'd for second prostate cancer variant https://t.co/ypFso4GGRh

[Pharma Commons @PharmaCommons]

leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology https://t.co/cYqgkPG442

[Pharma Commons @PharmaCommons]

Could Amgen soften the Neulasta biosimilar blow with an Alexion buy? https://t.co/fohw2B6pyQ

[Pharma Commons @PharmaCommons]

Amgen seeks FDA nod for osteoporosis therapy https://t.co/xujh4VN2SV

[Pharma Commons @PharmaCommons]

FDA AdComm backs GlaxoSmithKline’s 1-shot P. vivax malaria therapy https://t.co/yjoD08Zk4s

[Pharma Commons @PharmaCommons]

NICE backs AZ’ asthma biologic Fasenra https://t.co/ciDePRuh51

[Pharma Commons @PharmaCommons]

AbbVie’s blood cancer drug Ibrutinib fails in phase 3 DLBCL trial https://t.co/y8WsyYTQFc

[Pharma Commons @PharmaCommons]

Verge Genomics Nabs $32M For Computation-Heavy Neuro Drug Discovery https://t.co/qRgXlwijrV

[Pharma Commons @PharmaCommons]

Global Multiplex Biomarker Imaging Market Outlook 2018-2023: Abcam, Bio-Rad, US Biomax, PerkinElmer, Thermo ... - Detroit News 24 (press release) (blog) https://t.co/UbfQx13rA2

[Pharma Commons @PharmaCommons]

UCB, Amgen refile osteoporosis drug Evenity https://t.co/3fDEwOzCOb

[Pharma Commons @PharmaCommons]

Merck KGaA Aktie Es luft nicht rund https://t.co/dDL6dSJ3tm

[Pharma Commons @PharmaCommons]

Can Mylan dodge Pfizer's Remicade woes with a low-priced Neulasta copy? https://t.co/qUdLTfUJff

[Pharma Commons @PharmaCommons]

Roche Holding Aktie berzeugender Jahresauftakt https://t.co/mNgylIKf9i

[Pharma Commons @PharmaCommons]

Adempas maker Bayer connects hypertension patients with new mentoring group https://t.co/QP5UIsViR4

[Pharma Commons @PharmaCommons]

CluePoints, ONO in Four-Year RBM Pact https://t.co/gQQ9UZkClL

[Pharma Commons @PharmaCommons]

Chutes & Ladders—Gilead clinical director joins Nimbus to help lead drug discovery https://t.co/MDOAHC1bjw

[Pharma Commons @PharmaCommons]

FiercePharmaAsia—Biogen-Eisai Alzheimer’s win, Otsuka deals, Samsung BioLogics criminal probe https://t.co/Fqixtn58pO

[Pharma Commons @PharmaCommons]

Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More https://t.co/KWVdCcgNSk